| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/16/2000 | WO2000000500A3 Polyketides and their synthesis |
| 03/16/2000 | WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY |
| 03/16/2000 | CA2343156A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
| 03/16/2000 | CA2341349A1 Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof |
| 03/15/2000 | EP0985732A2 Trimeric chimera protein and collagen matrix containing chimera protein |
| 03/15/2000 | EP0984986A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor |
| 03/15/2000 | EP0610286B1 Recombinant immunotoxins |
| 03/15/2000 | CN1247568A Fibroblast growth factor homologs |
| 03/15/2000 | CN1247195A Thrombolytic fusion protein targeting thrombus |
| 03/14/2000 | US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues |
| 03/14/2000 | US6037133 IκBEGFP constructs, cell lines and methods of use |
| 03/14/2000 | US6036959 HCMV/HSV fusion glycoproteins |
| 03/14/2000 | CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/14/2000 | CA1340926C Human rhinovirus peptides |
| 03/09/2000 | WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 03/09/2000 | WO2000012727A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
| 03/09/2000 | WO2000012544A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 03/09/2000 | WO2000012536A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/09/2000 | WO2000012126A1 Autoantibody inhibitors |
| 03/09/2000 | CA2351547A1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/09/2000 | CA2340796A1 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 03/09/2000 | CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 03/08/2000 | EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission |
| 03/08/2000 | EP0983360A1 Smad7 and uses thereof |
| 03/08/2000 | EP0983357A1 Modulators of tissue regeneration |
| 03/08/2000 | EP0983089A1 Therapeutic or prophylactic use of fibronectin-binding protein i (sfbi) as adjuvant |
| 03/08/2000 | EP0804596A4 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4 |
| 03/08/2000 | EP0619843B1 Icams immunoglobulin constant region soluble fusion proteins |
| 03/08/2000 | CN1246799A Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 03/07/2000 | US6034229 BMP-15 compositions |
| 03/07/2000 | US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus |
| 03/02/2000 | WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM) |
| 03/02/2000 | WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof |
| 03/02/2000 | WO2000011152A1 Streptavidin mutants having secondary functional domains |
| 03/02/2000 | WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins |
| 03/02/2000 | WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 03/02/2000 | WO2000010598A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 03/02/2000 | WO1999055367A9 INTERNALIZING ErbB2 ANTIBODIES |
| 03/02/2000 | CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 03/02/2000 | CA2340595A1 Streptavidin mutants having secondary functional domains |
| 03/02/2000 | CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof |
| 03/01/2000 | EP0981618A1 Apo-2 RECEPTOR |
| 03/01/2000 | EP0981606A2 Method and construct for inhibition of cell migration |
| 03/01/2000 | EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 03/01/2000 | EP0981541A1 Psca: prostate stem cell antigen |
| 03/01/2000 | CN1246154A OB fusion protein compositions and methods |
| 02/29/2000 | US6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
| 02/29/2000 | US6030790 Kit for detecting active human parathyroid hormone including two sets of antibodies or antibody fragments; for diagnosis |
| 02/29/2000 | US6030772 Neutralizing antibodies against HIV infection |
| 02/29/2000 | US6030771 Mosaic protein and restriction endonuclease assisted ligation method for making the same |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009716A1 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009143A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/24/2000 | CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/23/2000 | EP0980436A1 Increased production of proteins by using chaperone-like proteins |
| 02/23/2000 | EP0980435A1 Human prohormone convertase 4 |
| 02/23/2000 | EP0980432A1 Chimeric opg polypeptides |
| 02/23/2000 | EP0980429A2 Human toll-like receptor proteins, related reagents and methods |
| 02/23/2000 | CN1245534A Mammalian cell surface antigens and relating reagents |
| 02/23/2000 | CN1245533A Mammalian chemokines |
| 02/23/2000 | CN1245503A Oil bodies and associated proteins as affinity matrices |
| 02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
| 02/22/2000 | US6027927 Human trk receptors and neurotrophic factor inhibitors |
| 02/22/2000 | US6027921 Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins |
| 02/22/2000 | US6027910 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
| 02/22/2000 | CA2071630C Hybrid protein c |
| 02/22/2000 | CA1340908C Methods of producing secreted receptor analogs and biologically active peptide dimers |
| 02/17/2000 | WO2000008444A1 Fluorescent assay for biological systems |
| 02/17/2000 | WO2000008443A1 Multiple frequency fluorescence lifetime imaging |
| 02/17/2000 | WO2000008158A2 Molecules designated ldcam |
| 02/17/2000 | WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58 |
| 02/17/2000 | WO2000008054A1 Modified green fluorescent protein |
| 02/17/2000 | WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | WO2000008043A2 Prevention and treatment of viral disease |
| 02/17/2000 | WO2000007631A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 02/17/2000 | WO1999057241A9 Myelin basic protein peptides and uses thereof |
| 02/17/2000 | CA2338983A1 Prevention and treatment of viral disease |
| 02/17/2000 | CA2337741A1 Pancreatic and ovarian polypeptide, zsig58 |
| 02/17/2000 | CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/16/2000 | EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein |
| 02/16/2000 | EP0979282A1 Rat st38.2 chemokine |
| 02/16/2000 | EP0979102A1 Polyalkylene oxide-modified single chain polypeptides |
| 02/16/2000 | CN1244870A Tissue specific expression of retinoblastoma protein |
| 02/16/2000 | CN1244803A Soluble CTLA4 mutant molecules and uses thereof |
| 02/15/2000 | US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae |
| 02/15/2000 | US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 02/15/2000 | US6025325 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same |
| 02/15/2000 | US6025166 Human trk receptors and neurotrophic factor inhibitors |
| 02/15/2000 | US6025144 Immunoassay test kit for measuring bone resorption |
| 02/15/2000 | CA2005300C Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
| 02/10/2000 | WO2000006747A2 Enzymes for biopolymer production |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006741A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006740A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |